Get the Stockscreener App
8.19
3.76%
-0.32
After Hours:
8.52
0.33
+4.03%
Delcath Systems Inc stock is traded at $8.19, with a volume of 1.00M.
It is down -3.76% in the last 24 hours and down -28.28% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
See More
Previous Close:
$8.51
Open:
$8.67
24h Volume:
1.00M
Relative Volume:
1.22
Market Cap:
$286.50M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-2.9043
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
-4.88%
1M Performance:
-28.28%
6M Performance:
-54.42%
1Y Performance:
-14.95%
1-Day Range:
$8.12
$8.7763
1-Week Range:
$8.12
$9.19
52-Week Range:
$8.12
$18.23
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
8.19 | 300.52M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
123.97 | 219.36B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.60 | 143.81B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
360.48 | 139.29B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.35 | 128.70B | 34.76B | 4.79B | 5.30B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
84.09 | 49.92B | 5.88B | 1.34B | 799.60M | 2.3489 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Delcath Systems board authorizes $25 million share repurchase program By Investing.com - Investing.com South Africa
Delcath Systems (DCTH) Initiates $25 Million Share Buyback Progr - GuruFocus
Delcath Systems Announces $25M Share Buyback Plan - TipRanks
Delcath Systems authorizes $25 million share repurchase program - Investing.com
Delcath Systems authorizes $25 million share repurchase program By Investing.com - Investing.com Australia
Domino's Pizza (Nasdaq: DPZ) brings back $9.99 any-topping pizzas promotion - Stock Titan
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program - Yahoo Finance Singapore
Can Delcath Systems Inc. (DV3R) stock attract ESG investmentsWeekly Loss Report & Technical Analysis for Trade Confirmation - newser.com
What analyst consensus says on Delcath Systems Inc. stockBear Alert & Verified Trade Idea Suggestions - newser.com
How supply shortages influence Delcath Systems Inc. (DV3R) stockJuly 2025 Recap & Safe Capital Investment Plans - newser.com
How Delcath Systems Inc. (DV3R) stock reacts to Fed tighteningDollar Strength & Free Reliable Trade Execution Plans - newser.com
Will Delcath Systems Inc. stock reach all time highs in 2025Market Performance Recap & AI Driven Stock Price Forecasts - newser.com
Can Delcath Systems Inc. (DV3R) stock beat analyst consensusMarket Sentiment Summary & Fast Exit/Entry Strategy Plans - newser.com
Real time breakdown of Delcath Systems Inc. stock performanceJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - newser.com
Why Delcath Systems Inc. (DV3R) stock trades below fair value2025 Valuation Update & Weekly High Return Opportunities - newser.com
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma - BioSpace
Is Delcath Systems Inc. showing signs of accumulation - newser.com
Will Delcath Systems Inc. benefit from macro trends2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Will Delcath Systems Inc. (DV3R) stock issue positive guidanceMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Volatility clustering patterns for Delcath Systems Inc.Breakout Watch & Free Growth Oriented Trading Recommendations - newser.com
Delcath Systems (DCTH) Highlights Promising Results for Liver Me - GuruFocus
H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT - Insider Monkey
10 Fast-Growing Small Cap Stocks to Buy According to Analysts - Insider Monkey
Delcath Systems Shares Tick Higher After Study Highlights Strong Outcomes for Liver Cancer Treatment - MSN
Delcath Systems Reports Positive CHOPIN Trial Results - MSN
Is it time to cut losses on Delcath Systems Inc.Quarterly Market Summary & Weekly Stock Breakout Alerts - newser.com
How to use a screener to detect Delcath Systems Inc. breakoutsTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Evaluating Delcath Systems Inc. with trendline analysisFed Meeting & High Conviction Trade Alerts - newser.com
Delcath Systems announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Delcath Systems (NASDAQ:DCTH) CEO Gerard Michel Acquires 11,500 Shares of Stock - MarketBeat
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.66%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):